Observational, Randomized, Prospective Study of the Impact of Digital Health Interventions on Symptom and Side-Effect Management in Patients With Metastatic Sarcoma

Inclusion Criteria

Inclusion Criteria: * Age of ≥ 18 years. * Diagnosis of locally advanced or metastatic sarcoma of any location and origin. * Ability to understand and operate in a digital environment. * Patients planned to start standard of care treatment within the next month, or are currently undergoing standard of care treatment of any line. * Treatments include surgery, radiotherapy, chemotherapy, immunotherapy, targeted therapy, hormonal therapy, or any combination of the above. Exclusion Criteria: * Limited ability or willingness to report side-effects on an online platform. * Performance status \>3. * Life expectancy of \<6 months. * Participation in an interventional clinical trial with investigational drugs or devices.